Open AccessComparison of Narrowband UV-B With Psoralen–UV-A Phototherapy for Patients With Early-Stage Mycosis Fungoides
Author(s) -
Kevin Phan,
Vignesh Ramachandran,
Hiva Fassihi,
Deshan F. Sebaratnam
Publication year - 2019
Publication title -
jama dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.128
H-Index - 166
eISSN - 2168-6084
pISSN - 2168-6068
DOI - 10.1001/jamadermatol.2018.5204
Subject(s) - medicine , mycosis fungoides , dermatology , adverse effect , puva therapy , erythema , cochrane library , cutaneous t cell lymphoma , stage (stratigraphy) , systematic review , randomized controlled trial , medline , surgery , lymphoma , psoriasis , paleontology , biology , political science , law
Phototherapy is one of the mainstays of treatment for early mycosis fungoides (MF). The most common modalities are psoralen-UV-A (PUVA) and narrowband UV-B (NBUVB).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom